“…Since alterations of the cellular epigenome usually precede morphologic changes and genetic alterations, identification of related aberrant DNA methylation profiles according to specific inflammation milieu may serve as a reasonable early diagnostic marker and an intervention target for CCA. Liver fluke infection (opisthorchis viverrini, or less frequently, clonorchis sinensis) RUNX3 (49.1%) [70] ; p14 (40.2%), p15 (48.9%), p16 (28.3%) [21] ; hMLH1 (44.6%) [71] Hepatolithiasis p16 (100% [72] , 54.6% [73] ); TFF1 (37.5%) [74] Biliary malformation (congenital choledochal cysts, caroli's disease, etc) NA Thorotrast hMLH1 (45.8%), hMSH2 (25.0%) [23] …”